A Rapid and Sensitive Microfluidics-Based Tool for Seroprevalence Immunity Assessment of COVID-19 and Vaccination-Induced Humoral Antibody Response at the Point of Care

As of 8 August 2022, SARS-CoV-2, the causative agent of COVID-19, has infected over 585 million people and resulted in more than 6.42 million deaths worldwide. While approved SARS-CoV-2 spike (S) protein-based vaccines induce robust seroconversion in most individuals, dramatically reducing disease s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajsri, Kritika Srinivasan, McRae, Michael P., Simmons, Glennon W., Christodoulides, Nicolaos J., Matz, Hanover, Dooley, Helen, Koide, Akiko, Koide, Shohei, McDevitt, John T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405565/
https://www.ncbi.nlm.nih.gov/pubmed/36005017
http://dx.doi.org/10.3390/bios12080621

Ejemplares similares

Ejemplares similares